Natural Supplements for COVID19—Background, Rationale, and Clinical Trials.

Bibliographic Details
Title: Natural Supplements for COVID19—Background, Rationale, and Clinical Trials.
Authors: Hermel, Melody, Sweeney, Megan, Ni, Yu-Ming, Bonakdar, Robert, Triffon, Douglas, Suhar, Christopher, Mehta, Sandeep, Dalhoumi, Sarah, Gray, James
Source: Journal of Evidence-Based Integrative Medicine; 9/13/2021, p1-16, 16p
Subject Terms: BIOTHERAPY, COVID-19, CLINICAL trials, POLYPHENOLS, GUT microbiome, VITAMIN C, DIET, CHOLECALCIFEROL, DIETARY supplements, PROBIOTICS, MELATONIN, MICRONUTRIENTS, CANNABINOIDS, ZINC, COVID-19 pandemic
Abstract: Worldwide, the turmoil of the SARS-CoV-2 (COVID-19) pandemic has generated a burst of research efforts in search of effective prevention and treatment modalities. Current recommendations on natural supplements arise from mostly anecdotal evidence in other viral infections and expert opinion, and many clinical trials are ongoing. Here the authors review the evidence and rationale for the use of natural supplements for prevention and treatment of COVID-19, including those with potential benefit and those with potential harms. Specifically, the authors review probiotics, dietary patterns, micronutrients, antioxidants, polyphenols, melatonin, and cannabinoids. Authors critically evaluated and summarized the biomedical literature published in peer-reviewed journals, preprint servers, and current guidelines recommended by expert scientific governing bodies. Ongoing and future trials registered on clinicaltrials.gov were also recorded, appraised, and considered in conjunction with the literature findings. In light of the controversial issues surrounding the manufacturing and marketing of natural supplements and limited scientific evidence available, the authors assessed the available data and present this review to equip clinicians with the necessary information regarding the evidence for and potential harms of usage to promote open discussions with patients who are considering dietary supplements to prevent and treat COVID-19. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Evidence-Based Integrative Medicine is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:2515690X
DOI:10.1177/2515690X211036875
Published in:Journal of Evidence-Based Integrative Medicine
Language:English